Fact CheckerSign in

NCT05462951Completed

Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer

Phase 0 Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer

Source: ClinicalTrials.gov · Last updated 6 Jul 2026

Brief summary (registry, in English)

This is a phase 0 clinical trial of molecular biomarkers in women with uterine cervix cancer. Women receive standard-of-care radiochemotherapy followed by brachytherapy. Blood samples are obtained to detect circulating levels of deoxyribonucleotides, human papillomavirus DNA, and circulating tumor cells.

Status (registry)
Completed
Study type
Observational
Enrollment
19 (actual)
First submitted
8 Jul 2022
Start date
3 Jan 2023
Primary completion date
9 Jun 2025
Lead sponsor
Denise Fabian
NCT number
NCT05462951

What you commit to

  • Study type: Observational
  • Participants enrolled: 19
  • From 3 Jan 2023 to the primary completion date, 9 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Presence of another concurrent active invasive malignancy
  • prior pelvic radiotherapy for any reason that would contribute radiation dose that would exceed tolerance of normal tissues at the discretion of the treating physician.

Other illness

  • Prior invasive malignancy diagnosed within the last three years except for \[1\] non-melanoma skin cancer or \[2\] prior in situ carcinoma of the cervix

Who the study is looking for

  • \- Untreated pathologically or cytologically-confirmed diagnosis of stage IB3 (\> 4cm), II, III, or IVA (FIGO 2018) squamous, adenosquamous, or adenocarcinoma of the uterine cervix not amenable to curative surgery alone.

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Markey Cancer Center
Coordinator of this site? Confirm its status
LexingtonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.